InsiderClue
Insiders · Profile

Von Seggern Christopher

Chief Commercial Officer at Xenon Pharmaceuticals. Filing since 6 Dec 2021. CIK 0001821192

Company
Date
Role
Action
Shares
Amount
Of holding
XENE Xenon Pharmaceuticals Inc.
6 Dec 2021
Chief Commercial Officer
Bought
4,000
$97.60K
opened
1 decision on file.